We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+30.63%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$320M
AUM Growth
-$34.7M
Cap. Flow
-$76.2M
Cap. Flow %
-23.82%
Top 10 Hldgs %
60.71%
Holding
47
New
7
Increased
14
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$13.9M
2
BLZE icon
Backblaze
BLZE
+$12.2M
3
VSTM icon
Verastem
VSTM
+$10.5M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$6.73M
5
COYA icon
Coya Therapeutics
COYA
+$3.76M

Top Sells

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$13.8M
2
GLW icon
Corning
GLW
+$7.11M
3
CLRB icon
Cellectar Biosciences
CLRB
+$6.84M
4
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$4.52M
5
DCTH icon
Delcath Systems
DCTH
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 53.56%
2 Technology 20.77%
3 Industrials 8.63%
4 Communication Services 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRCE
26
Grace Therapeutics
GRCE
$34.5M
$1.96M 0.61%
521,083
-120,000
-19% -$411K
FKWL icon
27
Franklin Wireless
FKWL
$26.8M
$1.91M 0.6%
390,000
– –
APRE icon
28
Aprea Therapeutics
APRE
$7.83M
$1.77M 0.55%
539,300
– –
INAB icon
29
IN8bio
INAB
$9.55M
$1.59M 0.5%
206,396
+150,575
+270% +$1.32M
INO icon
30
Inovio Pharmaceuticals
INO
$69.6M
$1.2M 0.37%
+654,115
New +$2.9M
BFRI icon
31
Biofrontera
BFRI
$16M
$884K 0.28%
811,097
+309,663
+62% +$293K
KPRX icon
32
Kiora Pharmaceuticals
KPRX
$11.3M
$850K 0.27%
255,555
– –
KALA icon
33
KALA BIO
KALA
$14.2M
$842K 0.26%
+2,426
New +$765K
CNSY
34
Cerenome, Inc. Common Stock
CNSY
$26.6M
$645K 0.2%
22,436
– –
PHGE icon
35
BiomX
PHGE
$1.72M
$632K 0.2%
45,547
– –
SMTK
36
SmartKem
SMTK
$3.93M
$456K 0.14%
156,487
+21,800
+16% +$72.6K
XAIR icon
37
Beyond Air
XAIR
$4.01M
$355K 0.11%
2,479
-6,528
-72% -$1.17M
MCHX icon
38
Marchex
MCHX
$80.2M
$347K 0.11%
198,100
– –
APPS icon
39
Digital Turbine
APPS
$1.73B
– –
-4,490,140
Closed -$13.8M
CLRB icon
40
Cellectar Biosciences
CLRB
$20.1M
– –
-106,580
Closed -$6.84M
EVOK
41
DELISTED
Evoke Pharma
EVOK
– –
-70,546
Closed -$339K
IMMX icon
42
Immix Biopharma
IMMX
$716M
– –
-1,123,663
Closed -$1.67M
MRAM icon
43
Everspin Technologies
MRAM
$367M
– –
-373,888
Closed -$2.21M
MX icon
44
Magnachip Semiconductor
MX
$141M
– –
-450,000
Closed -$2.1M
SVREW
45
SaverOne 2014 Ltd Warrant
SVREW
– –
-568,194
Closed -$45.5K
XBI icon
46
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-500,000
Closed -$110M
EGRX
47
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-1,211,509
Closed -$4.52M
1
2

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $738M AUM 32.56% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return

AIGH Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, AIGH Capital Management held 47 positions worth $320M, down 9.8% from $355M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AIGH Capital Management withdrew a net $76.2M in Q4 2024, closing 9 positions and reducing 8 holdings. Its most notable exit was Digital Turbine, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Marvell Technology worth $16.6M.

  • AIGH Capital Management's largest Q4 2024 buy was Marvell Technology: 150,000 shares worth $16.6M.
  • AIGH Capital Management added most to Coya Therapeutics in Q4 2024, an estimated $3.76M increase.
  • AIGH Capital Management's biggest Q4 2024 reduction was Corning, cutting an estimated $7.11M.
  • AIGH Capital Management fully exited Digital Turbine in Q4 2024, selling an estimated $13.8M.
  • AIGH Capital Management's ten largest holdings make up 61% of its $320M portfolio in Q4 2024.
  • AIGH Capital Management opened 7 new positions and closed 9 in Q4 2024.
  • AIGH Capital Management's portfolio value fell 9.8% quarter-over-quarter to $320M.

Based on AIGH Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.